The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects.
Johns DG, Behm DJ, Walker DJ, Ao Z, Shapland EM, Daniels DA, Riddick M, Dowell S, Staton PC, Green P, Shabon U, Bao W, Aiyar N, Yue TL, Brown AJ, Morrison AD, Douglas SA.
Johns DG, et al.
Br J Pharmacol. 2007 Nov;152(5):825-31. doi: 10.1038/sj.bjp.0707419. Epub 2007 Aug 20.
Br J Pharmacol. 2007.
PMID: 17704827
Free PMC article.